Creative Medical Technology Holdings, Inc.
CELZ
$3.16
-$0.035-1.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00% | -- | -- |
| Cost of Revenue | -- | -- | 0.00% | -- | -- |
| Gross Profit | -- | -- | 0.00% | -- | -- |
| SG&A Expenses | 8.19% | 32.30% | -0.40% | -6.10% | -21.34% |
| Depreciation & Amortization | 4.78% | 4.44% | -11.37% | 27.39% | 27.39% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.64% | 48.12% | 6.42% | -28.37% | 37.02% |
| Operating Income | 22.26% | -47.85% | -6.43% | 28.09% | -36.35% |
| Income Before Tax | 20.83% | -57.28% | -10.46% | 28.47% | -41.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.83% | -57.28% | -10.46% | 28.47% | -41.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.83% | -57.28% | -10.46% | 28.47% | -41.34% |
| EBIT | 22.26% | -47.85% | -6.43% | 28.09% | -36.35% |
| EBITDA | 22.76% | -49.00% | -6.69% | 28.93% | -36.53% |
| EPS Basic | 56.89% | -12.87% | 10.39% | 26.44% | -41.81% |
| Normalized Basic EPS | 56.89% | -12.86% | 10.39% | 26.45% | -41.82% |
| EPS Diluted | 56.89% | -12.87% | 10.39% | 26.44% | -41.81% |
| Normalized Diluted EPS | 56.89% | -12.86% | 10.39% | 26.45% | -41.82% |
| Average Basic Shares Outstanding | 83.64% | 39.35% | 23.26% | -2.73% | -0.33% |
| Average Diluted Shares Outstanding | 83.64% | 39.35% | 23.26% | -2.73% | -0.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |